These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9052812)

  • 1. The use of upper extremity anthropometrics in the clinical assessment of patients with amyotrophic lateral sclerosis.
    Kasarskis EJ; Berryman S; English T; Nyland J; Vanderleest JG; Schneider A; Berger R; McClain C
    Muscle Nerve; 1997 Mar; 20(3):330-5. PubMed ID: 9052812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
    Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group.
    Neurology; 1996 May; 46(5):1244-9. PubMed ID: 8628460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group.
    Miller RG; Petajan JH; Bryan WW; Armon C; Barohn RJ; Goodpasture JC; Hoagland RJ; Parry GJ; Ross MA; Stromatt SC
    Ann Neurol; 1996 Feb; 39(2):256-60. PubMed ID: 8967757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum CNTF level in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Eur Cytokine Netw; 2003; 14(3):192-4. PubMed ID: 14656696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrical impedance myography to assess outcome in amyotrophic lateral sclerosis clinical trials.
    Rutkove SB; Zhang H; Schoenfeld DA; Raynor EM; Shefner JM; Cudkowicz ME; Chin AB; Aaron R; Shiffman CA
    Clin Neurophysiol; 2007 Nov; 118(11):2413-8. PubMed ID: 17897874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey.
    Clavelou P; Blanquet M; Peyrol F; Ouchchane L; Gerbaud L
    J Neurol Sci; 2013 Aug; 331(1-2):126-31. PubMed ID: 23809193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthropometric measurement of muscle mass: revised equations for calculating bone-free arm muscle area.
    Heymsfield SB; McManus C; Smith J; Stevens V; Nixon DW
    Am J Clin Nutr; 1982 Oct; 36(4):680-90. PubMed ID: 7124671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I study of recombinant human ciliary neurotrophic factor (rHCNTF) in patients with amyotrophic lateral sclerosis. The ALS CNTF Treatment Study (ACTS) Phase I-II Study Group.
    Clin Neuropharmacol; 1995 Dec; 18(6):515-32. PubMed ID: 8681312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group.
    Stambler N; Charatan M; Cedarbaum JM
    Neurology; 1998 Jan; 50(1):66-72. PubMed ID: 9443459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients.
    Aebischer P; Schluep M; Déglon N; Joseph JM; Hirt L; Heyd B; Goddard M; Hammang JP; Zurn AD; Kato AC; Regli F; Baetge EE
    Nat Med; 1996 Jun; 2(6):696-9. PubMed ID: 8640564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical trial of verapamil in amyotrophic lateral sclerosis.
    Miller RG; Smith SA; Murphy JR; Brinkmann JR; Graves J; Mendoza M; Sands ML; Ringel SP
    Muscle Nerve; 1996 Apr; 19(4):511-5. PubMed ID: 8622731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.
    Petrou P; Gothelf Y; Argov Z; Gotkine M; Levy YS; Kassis I; Vaknin-Dembinsky A; Ben-Hur T; Offen D; Abramsky O; Melamed E; Karussis D
    JAMA Neurol; 2016 Mar; 73(3):337-44. PubMed ID: 26751635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular magnetic stimulation counteracts muscle decline in ALS patients: results of a randomized, double-blind, controlled study.
    Musarò A; Dobrowolny G; Cambieri C; Onesti E; Ceccanti M; Frasca V; Pisano A; Cerbelli B; Lepore E; Ruffolo G; Cifelli P; Roseti C; Giordano C; Gori MC; Palma E; Inghilleri M
    Sci Rep; 2019 Feb; 9(1):2837. PubMed ID: 30808899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upper extremity 3-dimensional reachable workspace assessment in amyotrophic lateral sclerosis by Kinect sensor.
    Oskarsson B; Joyce NC; De Bie E; Nicorici A; Bajcsy R; Kurillo G; Han JJ
    Muscle Nerve; 2016 Feb; 53(2):234-41. PubMed ID: 25965847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of a null mutation of the CNTF gene in familial amyotrophic lateral sclerosis.
    Orrell RW; King AW; Lane RJ; de Belleroche JS
    J Neurol Sci; 1995 Oct; 132(2):126-8. PubMed ID: 8543936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis.
    Al-Chalabi A; Scheffler MD; Smith BN; Parton MJ; Cudkowicz ME; Andersen PM; Hayden DL; Hansen VK; Turner MR; Shaw CE; Leigh PN; Brown RH
    Ann Neurol; 2003 Jul; 54(1):130-4. PubMed ID: 12838531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Deficiency of human ciliary neurotropic factor (CNTF) is not causally related to amyotrophic lateral sclerosis (ALS)].
    Takahashi R
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1543-5. PubMed ID: 8752458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum level of CNTF is elevated in patients with amyotrophic lateral sclerosis and correlates with site of disease onset.
    Laaksovirta H; Soinila S; Hukkanen V; Röyttä M; Soilu-Hänninen M
    Eur J Neurol; 2008 Apr; 15(4):355-9. PubMed ID: 18353124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.